A naukri.com initiative
Bioengineer
1w
164
Image Credit: Bioengineer
Administering Measles Vaccine Earlier Could Aid in Controlling Global Outbreak, Study Suggests
- A systematic review suggests vaccinating infants against measles as early as four months old to address waning maternal antibodies and vulnerability to infection before standard vaccination age.
- Maternal measles antibodies decline significantly by four months, leaving infants susceptible to infection, prompting reconsideration of current vaccination guidelines.
- Early vaccination between four to seven months shows promise in generating immune responses and preventing clinical measles during the vulnerable period of infancy.
- Challenges to advancing the vaccination schedule include potential vaccine efficacy attenuation and logistical complexities in implementation and coverage.
- Considerations must account for the role of school-aged children in measles transmission and address global vaccine hesitancy impacting herd immunity and outbreak control.
- Rising measles cases underscore the urgency for innovative strategies to combat outbreaks, with recommendations for rapid diagnostic testing and robust trials for revised vaccination schedules.
- Some countries are already adapting policies based on emerging evidence, exemplified by New Zealand endorsing additional measles vaccine doses for infants traveling to endemic regions.
- Persistent deficits in measles control necessitate evidence-based policy adaptations, especially in resource-limited settings where disease burden remains high.
- Revisiting vaccination timing offers an opportunity to strengthen infant protection and progress towards measles elimination, crucial in the fight against this global health threat.
- The interplay of immunology, epidemiology, and public health policy drives the need for nuanced strategies to navigate the challenges of measles control and save lives globally.
Read Full Article
9 Likes
For uninterrupted reading, download the app